Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
Crossref DOI link: https://doi.org/10.1186/s12929-016-0305-9
Published Online: 2016-12-03
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liao, Bin-Chi
Lin, Chia-Chi
Lee, Jih-Hsiang
Yang, James Chih-Hsin